Literature DB >> 26883242

The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism.

Gian Paolo Rossi1, Valeria Bisogni2.   

Abstract

Primary aldosteronism is one of the most common forms of secondary hypertension, but it is often under diagnosed, which leads to the development of cardiovascular damage, and excess costs for long-term drug treatment and management of complications. The aldosterone to renin ratio (ARR) is a key step for early detection of primary aldosteronism, but unfortunately is not easily estimated. This is because plasma aldosterone and renin are measured with different assays, which provide results in different units of measure, with ensuing difficulty of obtaining the calculation of the ARR in the proper units and impossibility of interpreting results with reference to established cut off values. Therefore, doctors are often unable to draw unambiguous conclusions to be used for the clinical decision-making. To the aim of making the diagnostic work-up easier, we have developed an Application that provide a swift calculation of the ARR regardless of the units of measure used for plasma aldosterone and renin values. If the concomitant serum potassium level is available the App also provides the patient's probability of having an aldosterone-producing adenoma based on a validated logistic discriminant analysis.

Entities:  

Keywords:  Aldosterone; Arterial hypertension; Primary aldosteronism; Ratio; Renin

Mesh:

Substances:

Year:  2016        PMID: 26883242     DOI: 10.1007/s40292-016-0132-9

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  12 in total

Review 1.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

2.  Screening for primary aldosteronism with a logistic multivariate discriminant analysis.

Authors:  G P Rossi; E Rossi; E Pavan; N Rosati; R Zecchel; A Semplicini; F Perazzoli; A C Pessina
Journal:  Clin Endocrinol (Oxf)       Date:  1998-12       Impact factor: 3.478

3.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.

Authors:  Tetsuo Nishikawa; Masao Omura; Fumitoshi Satoh; Hirotaka Shibata; Katsutoshi Takahashi; Naohisa Tamura; Akiyo Tanabe
Journal:  Endocr J       Date:  2011-08-09       Impact factor: 2.349

4.  Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.

Authors:  Gian Paolo Rossi; Teresa Maria Seccia; Gaetana Palumbo; Anna Belfiore; Giampaolo Bernini; Graziella Caridi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Anna Patalano; Damiano Rizzoni; Ermanno Rossi; Achille Cesare Pessina; Franco Mantero
Journal:  Hypertension       Date:  2009-11-23       Impact factor: 10.190

5.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

6.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.

Authors:  K Hiramatsu; T Yamada; Y Yukimura; I Komiya; K Ichikawa; M Ishihara; H Nagata; T Izumiyama
Journal:  Arch Intern Med       Date:  1981-11

7.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

8.  Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension.

Authors:  Gian Paolo Rossi; Giulio Ceolotto; Giacomo Rossitto; Teresa Maria Seccia; Giuseppe Maiolino; Chiara Berton; Daniela Basso; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2016-09-01       Impact factor: 3.694

9.  Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Stephen Sy; Colden Johanson; Heike E Kunzel; Martin Reincke; G Scott Gazelle; Milton C Weinstein; Thomas A Gaziano
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-11-10

10.  An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism.

Authors:  Gian Paolo Rossi; Richard J Auchus; Morris Brown; Jacques W M Lenders; Mitsuhide Naruse; Pierre Francois Plouin; Fumitoshi Satoh; William F Young
Journal:  Hypertension       Date:  2013-11-11       Impact factor: 10.190

View more
  1 in total

Review 1.  Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review.

Authors:  Stella Bernardi; Veronica Calabrò; Marco Cavallaro; Sara Lovriha; Rita Eramo; Bruno Fabris; Nicolò de Manzini; Chiara Dobrinja
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.